RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma (2016)
- Authors:
- USP affiliated authors: SILVA JUNIOR, WILSON ARAÚJO DA - FMRP ; ESPREAFICO, ENILZA MARIA - FMRP
- Unidade: FMRP
- DOI: 10.18632/oncotarget.9164
- Subjects: MELANOMA; RNA; PROLIFERAÇÃO CELULAR; EXPRESSÃO GÊNICA; TERAPÊUTICA MÉDICA
- Keywords: inRNA; rcRNA; TCGA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Oncotarget
- ISSN: 1949-2553
- Volume/Número/Paginação/Ano: v. 7, n. 24, p. 36711-36718, 2016
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
GOEDERT, Lucas et al. RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma. Oncotarget, v. 7, n. 24, p. 36711-36718, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.9164. Acesso em: 23 abr. 2024. -
APA
Goedert, L., Pereira, C. G., Roszik, J., Plaça, J. R., Cardoso, C., Chen, G., et al. (2016). RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma. Oncotarget, 7( 24), 36711-36718. doi:10.18632/oncotarget.9164 -
NLM
Goedert L, Pereira CG, Roszik J, Plaça JR, Cardoso C, Chen G, Deng W, Yennu-Nanda VG, Silva Júnior WA da, Davies MA, Espreáfico EM. RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma [Internet]. Oncotarget. 2016 ; 7( 24): 36711-36718.[citado 2024 abr. 23 ] Available from: https://doi.org/10.18632/oncotarget.9164 -
Vancouver
Goedert L, Pereira CG, Roszik J, Plaça JR, Cardoso C, Chen G, Deng W, Yennu-Nanda VG, Silva Júnior WA da, Davies MA, Espreáfico EM. RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma [Internet]. Oncotarget. 2016 ; 7( 24): 36711-36718.[citado 2024 abr. 23 ] Available from: https://doi.org/10.18632/oncotarget.9164 - RMEL3, a long noncoding RNA, induces tumor malignancy through the MAPK and PI3K pathways in BRAFV600E melanomas
- IncRNAs expression signatures in melanoma progression
- RNA-seq data analysis reveals differential expression of the long noncoding RNA ZEB1-AS1 during melanoma progression and its potential association with alterations in the MAPK pathway
- Mitochondrial genome instability influences energetic metabolism and tumor growth in melanoma
- Primary and metastatic melanoma reveal specific IncRNAs expression signatures
- The long noncoding RNA ZEB1-AS1 upregulation in melanoma and correlation with ZEB1 gene expression and invasiveness
- Identification of long noncoding RNAs deregulated in papillary thyroid cancer and correlated with BRAFV600E mutation by bioinformatics integrative analysis
- RNA-seq and bioinformatics analysis reveals the long noncoding RNA ZEB1-AS1 correlation with ZEB1 gene expression and association with invasive profile in melanoma
- Immunologicalization of myosin-v in the inner ear
- Identification and localization of myosin V in brain of Apis mellifera
Informações sobre o DOI: 10.18632/oncotarget.9164 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
